Overview
- Jurors awarded $18 million to Monica Kent and $22 million to Deborah Schultz and her husband after finding the company failed to warn about risks.
- Johnson & Johnson said it will immediately appeal and argued that scientific authorities do not support a causal link between cosmetic talc and ovarian cancer.
- The verdict is among the first to reach a jury since federal judges dismissed J&J’s latest Chapter 11 plan that had paused most cases.
- More than 67,000 plaintiffs have filed talc-related claims, with outcomes ranging from defense wins to large plaintiff awards, including a $966 million mesothelioma verdict in October.
- J&J maintains its products are safe and asbestos‑free and has replaced talc with cornstarch in the U.S. since 2020 and ended talc powder sales globally in 2023.